PET Scans Helped Tailor Induction Chemotherapy for Esophageal Cancers
January 17th 2017Using PET scans during induction chemotherapy for esophageal cancer, researchers were able to assess patient response to treatment and adjust their therapy, leading to an improved rate of pathologic complete response prior to surgery.
Zoledronic Acid-Celecoxib May Help Certain Prostate Cancer Patients
January 12th 2016Results from the large STAMPEDE trial suggest that the combination of zoledronic acid and celecoxib along with standard of care could improve failure-free survival in prostate cancer patients starting hormone therapy whose disease has metastasized.
Atezolizumab Shows Promise in Advanced Urothelial Carcinoma
January 11th 2016The anti-PD-L1 antibody atezolizumab showed significantly improved objective response rates compared to historic controls in a phase II study of patients with locally advanced or metastatic urothelial carcinoma previously treated with platinum-based therapy.